Literature DB >> 25512783

Association of genetic variants with diabetic nephropathy.

Saliha Rizvi1, Syed Tasleem Raza1, Farzana Mahdi1.   

Abstract

Diabetic nephropathy accounts for the most serious microvascular complication of diabetes mellitus. It is suggested that the prevalence of diabetic nephropathy will continue to increase in future posing a major challenge to the healthcare system resulting in increased morbidity and mortality. It occurs as a result of interaction between both genetic and environmental factors in individuals with both type 1 and type 2 diabetes. Genetic susceptibility has been proposed as an important factor for the development and progression of diabetic nephropathy, and various research efforts are being executed worldwide to identify the susceptibility gene for diabetic nephropathy. Numerous single nucleotide polymorphisms have been found in various genes giving rise to various gene variants which have been found to play a major role in genetic susceptibility to diabetic nephropathy. The risk of developing diabetic nephropathy is increased several times by inheriting risk alleles at susceptibility loci of various genes like ACE, IL, TNF-α, COL4A1, eNOS, SOD2, APOE, GLUT, etc. The identification of these genetic variants at a biomarker level could thus, allow the detection of those individuals at high risk for diabetic nephropathy which could thus help in the treatment, diagnosis and early prevention of the disease. The present review discusses about the various gene variants found till date to be associated with diabetic nephropathy.

Entities:  

Keywords:  Diabetes mellitus; Diabetic nephropathy; Gene variants; Genetic polymorphism; Nephropathy

Year:  2014        PMID: 25512783      PMCID: PMC4265867          DOI: 10.4239/wjd.v5.i6.809

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  69 in total

1.  Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy.

Authors:  J W Chen; P M Hansen; L Tarnow; A Hellgren; T Deckert; F Pociot
Journal:  Diabet Med       Date:  1997-02       Impact factor: 4.359

2.  The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients.

Authors:  Takashi Nomiyama; Yasushi Tanaka; Lianshan Piao; Keiko Nagasaka; Ken Sakai; Takeshi Ogihara; Kunihiro Nakajima; Hirotaka Watada; Ryuzo Kawamori
Journal:  J Hum Genet       Date:  2003       Impact factor: 3.172

3.  Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects.

Authors:  D P K Ng; B C Tai; D Koh; K W Tan; K S Chia
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

4.  Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.

Authors:  Samy Hadjadj; Riadh Belloum; Béatrice Bouhanick; Yves Gallois; Gérard Guilloteau; Gilles Chatellier; François Alhenc-Gelas; Michel Marre
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

5.  C-106T polymorphism in promoter of aldose reductase gene is a risk factor for diabetic nephropathy in type 2 diabetes patients with poor glycaemic control.

Authors:  Katarzyna Gosek; Dariusz Moczulski; Ewa Zukowska-Szczechowska; Wladyslaw Grzeszczak
Journal:  Nephron Exp Nephrol       Date:  2005-01-05

6.  Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients.

Authors:  Yazdan Jafari; Zohreh Rahimi; Asad Vaisi-Raygani; Mansour Rezaei
Journal:  Mol Cell Biochem       Date:  2011-03-06       Impact factor: 3.396

7.  Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus.

Authors:  M Neamat-Allah; S A Feeney; D A Savage; A P Maxwell; R L Hanson; W C Knowler; A M El Nahas; M E Plater; J Shaw; A J Boulton; G W Duff; A Cox
Journal:  Diabet Med       Date:  2001-11       Impact factor: 4.359

8.  Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes.

Authors:  W Grzeszczak; D K Moczulski; M Zychma; E Zukowska-Szczechowska; W Trautsolt; I Szydlowska
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

9.  Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with Type 2 diabetes.

Authors:  Arun K Tiwari; Pushplata Prasad; Thelma B K; K M Prasanna Kumar; A C Ammini; Arvind Gupta; Rajeev Gupta
Journal:  J Diabetes Complications       Date:  2008-04-16       Impact factor: 2.852

10.  Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy.

Authors:  Meredith A Bostrom; Barry I Freedman; Carl D Langefeld; Lingyi Liu; Pamela J Hicks; Donald W Bowden
Journal:  Diabetes       Date:  2008-12-03       Impact factor: 9.461

View more
  20 in total

1.  Association of fibronectin Msp iv polymorphism and diabetic nephropathy susceptibility in Chinese Han population.

Authors:  Jinxiang Gao; Xuezhong Zhang; Huiling Diao; Yunqi Liu; Min Lv; Hua Dong; Xiaomin Zhang; Yaning Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Profibrotic up-regulation of glucose transporter 1 by TGF-β involves activation of MEK and mammalian target of rapamycin complex 2 pathways.

Authors:  Mahefatiana Andrianifahanana; Danielle M Hernandez; Xueqian Yin; Jeong-Han Kang; Mi-Yeon Jung; Youli Wang; Eunhee S Yi; Anja C Roden; Andrew H Limper; Edward B Leof
Journal:  FASEB J       Date:  2016-08-01       Impact factor: 5.191

3.  Angiotensinogen (AGT) gene missense polymorphisms (rs699 and rs4762) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus.

Authors:  Jana Makuc; Maja Šeruga; Matej Završnik; Ines Cilenšek; Daniel Petrovič
Journal:  Bosn J Basic Med Sci       Date:  2017-08-20       Impact factor: 3.363

4.  Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy.

Authors:  Xueling Liao; Yanan Xiao; Ulf Elbelt; Karsten H Weylandt; Kanghui Li; Jie Deng; Ning Zeng; Chao Xue
Journal:  Biomed Res Int       Date:  2022-05-25       Impact factor: 3.246

5.  Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.

Authors:  Ying Shao; Huiwen Ren; Chuan Lv; Xiaoyu Ma; Can Wu; Qiuyue Wang
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633

Review 6.  Association of plasminogen activator inhibitor-1 4G5G Polymorphism with risk of diabetic nephropathy and retinopathy: a systematic review and meta-analysis.

Authors:  Seyed Alireza Dastgheib; Farzaneh Najafi; Ahmad Shajari; Reza Bahrami; Fatemeh Asadian; Jalal Sadeghizadeh-Yazdi; Elahe Akbarian; Seyed Alireza Emarati; Hossein Neamatzadeh
Journal:  J Diabetes Metab Disord       Date:  2020-11-03

7.  Aldose reductase (AC)n gene polymorphism in Iranian patients with type 2 diabetic microangiopathy; a case-control study.

Authors:  Mohammad Bagher Hashemi-Soteh; Ali Ahmadzadeh Amiri; Majid Reza Sheikh Rezaee; Amir Ahmadzadeh Amiri; Soleiman Olfat; Ahmad Ahmadzadeh Amiri
Journal:  Diabetol Int       Date:  2020-06-10

8.  The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.

Authors:  Emanuela Lapice; Antonella Monticelli; Sergio Cocozza; Michele Pinelli; Sara Cocozza; Dario Bruzzese; Gabriele Riccardi; Olga Vaccaro
Journal:  J Transl Med       Date:  2015-03-12       Impact factor: 5.531

Review 9.  Role of GNB3, NET, KCNJ11, TCF7L2 and GRL genes single nucleotide polymorphism in the risk prediction of type 2 diabetes mellitus.

Authors:  Saliha Rizvi; Syed Tasleem Raza; Qamar Rahman; Farzana Mahdi
Journal:  3 Biotech       Date:  2016-12-02       Impact factor: 2.406

10.  Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China.

Authors:  Xiaohong Xu; Jing Sun; Xiaomin Chang; Ji Wang; Manyu Luo; Kupper A Wintergerst; Lining Miao; Lu Cai
Journal:  J Cell Mol Med       Date:  2016-07-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.